Brief: ESSA Pharma Inc. Announces Definitive Agreement To Be Acquired By Xenotherapeutics, Inc., Backed By XOMA Royalty Corporation In All-Cash Transaction
14/07/2025 13:02
July 14 (Reuters) - ESSA Pharma Inc EPIX.O: ESSA PHARMA INC. ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY XENOTHERAPEUTICS, INC., BACKED BY XOMA ROYALTY CORPORATION IN ALL-CASH TRANSACTION ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE CVR FOR UP TO $2.95 MILLION ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE CASH PAYMENT PER SHARE ESSA PHARMA INC - SHAREHOLDERS ESTIMATED TO RECEIVE $1.91 PER SHARE ESSA PHARMA INC - AGREEMENT INCLUDES $2.5 MILLION TERMINATION FEE Source text: ID:nCNWS04TXa Further company coverage: EPIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ESSA Pharma
See all newsBrief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: ESSA Pharma Provides Update On Its Application To The Supreme Court Of British Columbia For Amended Interim Order
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics